Bionomics Operating Income 2022-2024 | NEUP
Bionomics operating income from 2022 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Bionomics Annual Operating Income
(Millions of US $) |
| 2024 |
$-18 |
| 2023 |
$-22 |
| 2022 |
$-16 |
| 2021 |
$-6 |
Bionomics Quarterly Operating Income
(Millions of US $) |
| 2024-09-30 |
$-4 |
| 2024-06-30 |
|
| 2023-12-31 |
|
| 2023-09-30 |
$-5 |
| 2023-06-30 |
|
| 2022-12-31 |
|
| 2022-06-30 |
|
| 2021-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.010B |
$0.000B |
|
Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.
|
